BOLT
Price:
$4.56
Market Cap:
$8.76M
Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the body's immune system to identify and eliminate cancerous cells. A key therapeutic in its pipeline is BDC-1001, an investigational treatment targeting the human epidermal growth factor receptor 2 (HER2). This compound is presently undergoing Phase I/II clinical evaluation for patients with HER2-positive solid tumors, including those exhibiting low HER2 expression. Beyond BDC-1001, the company is advancing several other programs: BDC-2034, which targets carcinoembryonic antigen for various indicati...[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
BOLT
According to Bolt Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.28. This represents a change of -15.59% compared to the average of -0.33 of the last 4 quarters.
The mean historical PE Ratio of Bolt Biotherapeutics, Inc. over the last ten years is -90.97. The current -0.28 PE Ratio has changed -69.22% with respect to the historical average. Over the past ten years (40 quarters), BOLT's PE Ratio was at its highest in in the March 2026 quarter at -0.26. The PE Ratio was at its lowest in in the March 2020 quarter at -260.51.
Average
-90.97
Median
-24.71
Minimum
-383.79
Maximum
-0.31
Discovering the peaks and valleys of Bolt Biotherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 127.18%
Maximum Annual PE Ratio = -0.31
Minimum Annual Increase = -95.27%
Minimum Annual PE Ratio = -383.79
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.31 | -95.27% |
| 2024 | -6.47 | -47.12% |
| 2023 | -12.24 | 11.02% |
| 2022 | -11.03 | -70.34% |
| 2021 | -37.18 | -90.31% |
| 2020 | -383.79 | 127.18% |
| 2019 | -168.94 | 56.65% |
The current PE Ratio of Bolt Biotherapeutics, Inc. (BOLT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.34
5-year avg
-13.44
10-year avg
-90.97
Bolt Biotherapeutics, Inc.’s PE Ratio is greater than Cellectar Biosciences, Inc. (-0.45), less than Sensei Biotherapeutics, Inc. (-0.09), less than AEON Biopharma, Inc. (-0.15), greater than Cingulate Inc. (-0.96), greater than Imunon, Inc. (-0.69), less than Lyra Therapeutics, Inc. (-0.24), greater than Marker Therapeutics, Inc. (-2.45), less than TransCode Therapeutics, Inc. (-0.12), greater than Evogene Ltd. (-0.48), greater than IN8bio, Inc. (-0.33),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.45 | $7.12M | |
| -0.09 | $17.45M | |
| -0.15 | $8.64M | |
| -0.96 | $27.36M | |
| -0.69 | $5.09M | |
| -0.24 | $781.13K | |
| -2.45 | $14.90M | |
| -0.12 | $5.07M | |
| -0.48 | $5.03M | |
| -0.33 | $6.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bolt Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bolt Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Bolt Biotherapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Bolt Biotherapeutics, Inc. (BOLT)?
What is the highest PE Ratio for Bolt Biotherapeutics, Inc. (BOLT)?
What is the 3-year average PE Ratio for Bolt Biotherapeutics, Inc. (BOLT)?
What is the 5-year average PE Ratio for Bolt Biotherapeutics, Inc. (BOLT)?
How does the current PE Ratio for Bolt Biotherapeutics, Inc. (BOLT) compare to its historical average?